Dr. Feldman on Study of Active Surveillance in Younger Men With Prostate Cancer | OncLive

Dr. Feldman on Study of Active Surveillance in Younger Men With Prostate Cancer

September 6, 2017

Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses a study of active surveillance in younger men with prostate cancer.

Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses a study of active surveillance in younger men with prostate cancer.

In this study, 432 men with a median age of 55 were put on active surveillance. Historically, men under 60 have not been recommended for active surveillance due to risk of aggressive disease or progression.

At 5 years, 75% of men remained on active surveillance, and at 10 years, 55% of men remained on active surveillance.


x